ADCYAP1 and migraine disorder: One possible explanation for non-response to CGRP-mAbs might be the existence of different subtypes of migraine, in which CGRP plays a key role in some patients while other neuropeptides such as pituitary adenylate cyclase-activating polypeptide or other mechanisms may play a predominant role in other patients (14).